Additional caution should be applied in the counselling of survivors of cancers diagnosed during adulthood given the paucity of data pertaining to the safety of GH in this population (in contrast to childhood cancer survivors) and differences in the most prevalent types of cancer between children (leukaemia and CNS malignancies) and adults (breast, prostate, and colon). Here, GH1 is linked to childhood malignant neoplasm.